Adequate 0 8 0 8 O
bone 9 13 9 13 O
marrow 14 20 14 20 O
, 20 21 20 21 O
renal 22 27 22 27 O
function 28 36 28 36 O
, 36 37 36 37 O
cardiac 38 45 38 45 O
, 45 46 45 46 O
and 47 50 47 50 O
pulmonary 51 60 51 60 O
function 61 69 61 69 O
, 69 70 69 70 O
negative 71 79 71 79 B-pregnancy
pregnancy 80 89 80 89 I-pregnancy
test 90 94 90 94 O
( 95 96 95 96 O
for 96 99 96 99 O
women 100 105 100 105 B-gender
) 105 106 105 106 O

Karnofsky 0 9 107 116 B-clinical_variable
> 10 11 117 118 O
50 11 13 118 120 B-lower_bound
% 13 14 120 121 I-lower_bound
( 15 16 122 123 O
> 16 17 123 124 O
age 17 20 124 127 B-age
16 21 23 128 130 B-lower_bound
) 23 24 130 131 O

Lanky 0 5 132 137 B-clinical_variable
> 6 7 138 139 O
50 7 9 139 141 B-lower_bound
( 10 11 142 143 O
< 11 12 143 144 O
age 12 15 144 147 B-age
16 16 18 148 150 B-upper_bound
) 18 19 150 151 O

Measurable 0 10 152 162 B-chronic_disease
disease 11 18 163 170 I-chronic_disease

No 0 2 171 173 O
prior 3 8 174 179 O
therapy 9 16 180 187 O
within 17 23 188 194 O
4 24 25 195 196 B-upper_bound
weeks 26 31 197 202 I-upper_bound
of 32 34 203 205 O
enrollment 35 45 206 216 O

Patients 0 8 217 225 O
with 9 13 226 230 O
known 14 19 231 236 O
contraindications 20 37 237 254 O
to 38 40 255 257 O
receiving 41 50 258 267 O
propranolol 51 62 268 279 B-allergy_name

Primary 0 7 280 287 B-chronic_disease
lymphedema 8 18 288 298 I-chronic_disease

Secondary 0 9 299 308 B-chronic_disease
lymphedema 10 20 309 319 I-chronic_disease

